Legend Biotech (LEGN) is a publicly traded Healthcare sector company. As of September 1, 2026, LEGN trades at $20.74 with a market cap of $3.87B and a P/E ratio of 0.00. LEGN moved +0.22% today. Year to date, LEGN is -4.42%; over the trailing twelve months it is -40.17%. Its 52-week range spans $16.24 to $45.30. Analyst consensus is buy with an average price target of $48.07. Rallies surfaces LEGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LEGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LEGN recently traded at $20.74. Market cap is $3.87B. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $20.74 |
| Market Cap | $3.87B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.30 |
| 52-Week Low | $16.24 |
| Volume | 75.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
10 analysts cover LEGN: 0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $48.07.